2022: a year in review

From a difficult start to a triumphant end, here are the most significant events that impacted pharmacy practice in 2022.

What transpired at the inaugural GP-Pharmacists Symposium?

PSA's inaugural GP Pharmacists Symposium underscored the expanding scope of the profession – and the policy gaps that still need closing.

Medicinal cannabis: Patient access and clinical evidence

In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...

Dapagliflozin for infertility for women with obesity

This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.

Optimising patient safety

Professor Parisa Aslani has dedicated her career to improving the quality use of medicines through better consumer information and adherence. She was conferred as...

Ocular changes

A patient inquiry about ocular changes may provide pharmacists with an opportunity to screen or refer patients to an optometrist.